The Europe Lateral Flow Assay Components Market was valued at $108.63 Million in 2025 and projected to reach to $135.27 Million by 2030, representing a compound annual growth rate of 4.5%. Europe's lateral flow assay components market is positioned for sustained growth through 2030, supported by robust healthcare spending, regulatory compliance frameworks, and widespread adoption of point-of-care testing solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe commands a significant share of the global lateral flow assay components market, valued at USD 108.63 million in 2025, driven by advanced healthcare infrastructure and stringent regulatory standards across EU member states.
The European market is projected to expand from USD 108.63 million (2025) to USD 135.27 million (2030) at a CAGR of 4.5%, outpacing the global growth rate of 4.4% and reflecting strong regional demand.
Germany leads European adoption with a market size of USD 33.11 million, followed by France (USD 23.74 million) and the UK (USD 11.79 million), establishing the region as a hub for diagnostic innovation.
Increasing demand for rapid, accessible diagnostic solutions across European healthcare systems is accelerating adoption of lateral flow assay components in clinical and home-use applications.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DRUG DEVELOPMENT & QUALITY TESTING (Application) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 4.4% from 2025 to 2030 |
| Largest Segment | CLINICAL TESTING (Application) |
| Market Size Base Year (Billions) | ~USD 0.39 (2025) |
| Revenue Forecast (Billions) | ~USD 0.49 (2030) |
| Segments Covered | Product, Membrane Type, Pad Type, Technique, Application, Type, End User |
7 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES | 8.35 | 8.73 | 9.14 | 9.6 | 10.1 | 10.65 | 11.25 | 11.91 | 5.4 |
| MEDICAL DEVICE MANUFACTURING COMPANIES | 16.83 | 17.33 | 17.88 | 18.48 | 19.16 | 19.9 | 20.7 | 21.58 | 3.8 |
| TOTAL | 25.18 | 26.06 | 27.02 | 28.08 | 29.26 | 30.54 | 31.95 | 33.48 | 4.4 |
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES | 33.92 | 35.49 | 37.22 | 39.1 | 41.19 | 43.48 | 45.98 | 48.72 | 5.5 |
| MEDICAL DEVICE MANUFACTURING COMPANIES | 67.09 | 69.16 | 71.41 | 73.88 | 76.66 | 79.67 | 82.96 | 86.55 | 3.9 |
| TOTAL | 101.01 | 104.65 | 108.63 | 112.98 | 117.84 | 123.15 | 128.95 | 135.27 | 4.5 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 33.11 Million |
| France | USD 23.74 Million |
| UK | USD 11.79 Million |
| Italy | USD 8.17 Million |
| Spain | USD 5.22 Million |
| Rest Of Europe | USD 18.84 Million |
Europe's lateral flow assay components market is valued at USD 108.63 million in 2025.
Europe's lateral flow assay components market is projected to reach USD 135.27 million by 2030.
Europe's lateral flow assay components market is expected to grow at a CAGR of 4.5% from 2025 to 2030.
Growth in Europe is driven by strong healthcare infrastructure, regulatory support, rising infectious disease prevalence, expansion of home-based testing, and increased adoption of point-of-care diagnostics.
Europe is significant due to its established manufacturing capabilities, stringent quality standards, advanced healthcare systems, and substantial investment in diagnostic innovation across member states.
The study focused on key activities to estimate the current market size for the lateral flow assay (LFA) components market. Extensive secondary research was conducted to gather information on the industry. The next step involved validating these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Various methods, such as top-down and bottom-up approaches, were used to calculate the total market size. Subsequently, market segmentation and data triangulation were employed to determine the sizes of segments and subsegments within the lateral flow assay components market.
The four steps involved in estimating the market size are:
The secondary research process involves extensively using secondary sources such as directories, databases (including Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings from companies, and publications from government agencies like the National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS). These sources are utilized to gather information for the global lateral flow assay components market study. They also help gather key details about the main players, market classification, and segmentation based on industry trends, down to the most detailed level, as well as significant developments related to market and technology perspectives. Additionally, a database of leading industry players was created using secondary data research.
In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations operating in the LFAs market and the lateral flow assay components market. Primary sources from the demand side include medical device manufacturing companies and medical device contract manufacturer companies.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were estimated based on revenue mapping of major product manufacturers and OEMs active in the worldwide lateral flow assay components market. All key service providers were identified at the global and/or regional, or country level. Revenue mapping for the respective business segments and sub-segments was conducted for the major players. The global lateral flow assay components market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After determining the overall market size using the method described above, the total market was divided into several segments. Data triangulation and market breakdown methods were used wherever applicable to complete the market segmentation process and obtain precise data for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both demand and supply sides.
LFA components typically include membranes (such as nitrocellulose, polyvinylidene difluoride, nylon, or polyether sulfone membranes with immobilized antibodies) and pads (such as sample, conjugate, and absorbent pads) that are fixed to an inert backing material to create the assay. These components can be used for various applications, including clinical testing, food and beverage testing, and drug-of-abuse detection testing, among others.
Full forecast, segment splits, and company analysis for all Lateral Flow Assay Components Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report